Want to join the conversation?
$WSM expects 2Q16 EPS of $0.54-0.60, net revenues of $1.145-1.175Bil and comparable brand revenue growth of 1-4%. For FY16, $WSM now expects non-GAAP EPS of $3.50-3.65, net revenues of $5.15-5.25Bil and comparable brand revenue growth of 3-6%. The company now sees FY16 non-GAAP operating margin of 9.8-10%, and income tax rate of 37-38%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?